GSI COMMERCE INC (GSIC)
Symbol Info
Listed Symbol GSIC
Name GSI COMMERCE INC
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-2.82
Price Info
21 Day Moving Average $29.5400
21 Day EMA $29.540000
50 Day Moving Average $29.5400
50 Day EMA $29.539960
200 Day EMA $29.272870
200 Day Moving Average 29.540000
52 Week High $
52 Week Low $-
52 Week Change $
Alpha 0.017149
Beta 0.9882
Standard Deviation 0.147577
R2 0.144019
Periods 48
Share Information
10 Day Average Volume -
20 Day Average Volume -
30 Day Average Volume -
50 Day Average Volume -
Outstanding Shares 26,149,689
Float Shares 25,704,644
Percent Float 98.30%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 96
Institute Holdings Date 2019-08-31
Institute Bought Previous 3 Months 12,468,374
Institute Holdings Percent 47.800000
Institute Sold Previous 3 Months 527,614
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 18
Insider Holdings Percent 1.70%
Insider Sold Previous 3 Months -
Insiders Shares Owned 445,045
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $-
21 Day Percent Change -
30 Day Price Change $-
30 Day Percent Change -
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $-
90 Day Percent Change -
Quarter To Date $-
Quarter To Date Percent -
180 Day Price Change $-
180 Day Percent Change -
200 Day Price Change $-
200 Day Percent Change -
Year To Date $-
Year To Date Percent -
Profile
Description Genocea Biosciences Inc is a US-based biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs. Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
Details
Issue Type CS
Market Cap $772,461,813
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 26,149,689
CEO William D. Clark
Employees 61
Last Audit UE
Classification
CIK 0001457612
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 100 Acorn Park Drive
Cambridge, MA 2140
Website http://www.genocea.com
Facisimile +1 617 500-0969
Telephone +1 617 876-8191
Email ir@genocea.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $52,623,930
Price To Sales -
Price To Free Cash -2.5
PE High Last 5 Years -
Price To Book 2.4
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 2.4
Financial Strength
Total Debt To Equity 0.6
Int Coverage -
Current Ratio 6.0
Leverage Ratio 3.2
Quick Ratio 5.9
Long Term Debt To Capital 0.31
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -49.32
Return On Equity -116.09
Return On Capital -68.7
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
GSIC
Gsi Commer..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.